HOME >> MEDICINE >> NEWS
International breast cancer prevention study launches in the United States and Canada

Boston-March 30, 2005 Today, a new clinical trial evaluating a novel approach to breast cancer prevention launched in the United States and Canada. Called the ExCel research study, this is the first North American clinical trial to evaluate the role of an aromatase inhibitor in the prevention of breast cancer.

Coordinated by the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG), the ExCel research study will examine the potential benefit of exemestane and its ability to prevent breast cancer in women who are at increased risk for the disease. Exemestane part of a class of drugs called aromatase inhibitors suppresses estrogen production, a key component in the development of some types of breast cancer. Exemestane could provide women with an alternative option to tamoxifen, the only drug FDA approved for prevention of breast cancer.

"Breast cancer is a major public health issue every 30 seconds somewhere in the world a woman is diagnosed with this disease," says Dr. Paul Goss, the ExCel research study chair.

"Thousands of women have already beat breast cancer thanks to recent research on aromatase inhibitors. As a result, we think this could be an effective approach to preventing it from developing in the first place."

The ExCel research study will follow more than 4,500 postmenopausal women from the U.S., Canada and Spain over a five year period. To be eligible, women must be 35 years of age or older and have an increased risk of developing breast cancer. Risk factors can include a woman's age, her family history of breast cancer, her age at first menstrual period and her age at first live birth.

Initial results of the trial could be available within four years and study investigators hope to see as much as a two-thirds reduction in the incidence of breast cancer among women in the treatment group.

Aromatase inhibitors are currently being used to treat breast cancer in wo
'"/>

Contact: Samantha Kaplan
samantha.kaplan@edelman.com
312-297-7439
Edelman Public Relations
30-Mar-2005


Page: 1 2 3 4

Related medicine news :

1. National Academies advisory: May 2 Symposium on International Science Policy
2. Awards & fellowships at the International & American Association for Dental Research General Session
3. Lectures, keynoters, symposia highlight International Dental Research meeting
4. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
5. International gathering of experts to share retinoblastoma breakthroughs
6. International trial of two microbicides begins
7. International gathering at UH examines top computer code
8. International trial finds benefits of breast MRI in women at high risk
9. International study provides culture-by-culture clues to family violence and abuse
10. St. Jude scientist wins International Society of Experimental Hematology award
11. International MRC trial finds a routine treatment for head injury may do more harm than good

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/12/2019)... ... June 12, 2019 , ... Ovation Travel Group, ... today announced that its Chairman and CEO Paul Metselaar has received the Children’s ... last Wednesday evening at New York City’s Capitale as part of the Children’s ...
(Date:6/12/2019)... ... June 12, 2019 , ... ... to the family of Best Sanitizers’ HACCP Footwear Sanitizing Unit equipment. The HACCP ... plants, pharmaceutical plants, clinical research labs, and clean rooms by reducing cross-contamination from ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... and developmental disabilities and their families recently received the promise of a two-million-dollar ... grant, gifted by The Tomlinson Foundation, would allow TERI to complete phase two ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... recent workshop with government regulators, biopharma companies, and academic thought leaders ... dystrophy (FSHD) . The Society is the world’s largest research-focused patient advocacy organization ...
(Date:6/6/2019)... ROSEMONT, Ill. (PRWEB) , ... June 06, 2019 ... ... between healthcare disciplines to treat patients with jaw deformities caused by juvenile idiopathic ... , The proposed algorithm suggests treatments based on factors such as progression of ...
Breaking Medicine News(10 mins):
(Date:6/14/2019)... ... , ... Land O' Lakes Chiropractor, Dr. Michael A. Craven of ... to help patients obtain useful information, read helpful articles, book appointments, and get updates ... Michael Craven is committed to helping his patients live a healthy and active ...
(Date:6/13/2019)... ... June 13, 2019 , ... ... front desk employee with a back problem, underscore the responsibility of employers to ... explores which employee accommodation requests are reasonable and which are not - from ...
(Date:6/13/2019)... ... June 13, 2019 , ... RxNT announced today that it has ... software solution . RxNT is a leader in healthcare technology solutions. This is the ... software users to highlight the best software products from North American small businesses. RxNT ...
Breaking Medicine Technology:
Cached News: